Tumor Necrosis Factor Alpha and Gamma Interferon are Required for the Development of Protective Immunity to Secondary Corynebacterium pseudotuberculosis Infection in Mice.-Reference-Cited by-同舟云学术

Tumor Necrosis Factor Alpha and Gamma Interferon are Required for the Development of Protective Immunity to Secondary Corynebacterium pseudotuberculosis Infection in Mice.

Published:1999 Issue:11 Volume:61 Page:1203-1208
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

Thi Bich LAN Dinh¹,MAKINO Sou-ichi¹,SHIRAHATA Toshikazu¹,YAMADA Manabu²,NAKANE Akio³

Affiliation:

1. Department of Veterinary Microbiology, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan

2. Department of Veterinary Pathology, Obihiro University of Agriculture and Veterinary Medicine, Obihiro 080-8555, Japan

3. Department of Bacteriology, Hirosaki University School of Medicine, 5 Zaifu-cho, Hirosaki 036-8216, Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

http://www.jstage.jst.go.jp/article/jvms/61/11/61_11_1203/_pdf

Reference25 articles.

1. 2) Appelberg, R., Castro, A. G., Pedrosa, J., Silva, R. A., Orme, I.M. and Minoprio, P. 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62: 3962-3971.

2. 3) Batey, R. G. 1986. Frequency and consequence of caseous lymphadenitis in sheep and lambs slaughtered at a Western Australian abattoir. Am. J. Vet. Res. 47: 482-485.

3. 4) Biberstein, E.L., Knight, H.D. and Jang, S. 1971. Two biotypes of Corynebacterium pseudotuberculosis. Vet. Rec. 25: 691-692.

4. 5) Brown, C.C. and Olander, H.J. 1987. Caseous lymphadenitis of goats and sheep: A review. Vet. Bull. 57: 1-11.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response of BALB/c mice infected with two strains of Corynebacterium pseudotuberculosis;Microbial Pathogenesis;2024-07

2. Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice;Vaccine;2021-04

3. Recombinant M. bovis BCG expressing the PLD protein promotes survival in mice challenged with a C. pseudotuberculosis virulent strain;Vaccine;2018-06

4. Quantitative Proteomic Analysis Reveals Changes in the Benchmark Corynebacterium pseudotuberculosis Biovar Equi Exoproteome after Passage in a Murine Host;Frontiers in Cellular and Infection Microbiology;2017-07-25

5. Putative virulence factors of Corynebacterium pseudotuberculosis FRC41: vaccine potential and protein expression;Microbial Cell Factories;2016-05-16